A novel drug class for the effective treatment of Giardia infections
A novel drug class for the effective treatment of Giardia infections
批准号:
LP210301109
负责人:
Prof Adam McCluskey
金额:
$20.36万
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2023
资助国家:
澳大利亚
项目状态:
未结题
起止时间:
2023-12-13 至 2026-12-12
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Companion animals play a pivotal role in the lifestyle of the average Australian family. The 9 million cats and dogs, residing in >65% of our households, have provided significant health and well-being benefits to owners, especially during COVID. Ensuring pet health is a primary obligation of pet ownership. Giardia infections (Giardia duodenalis, with 94% of infections in dogs identified as Assemblage A) is the most prevalent enteric parasite identified globally in dogs. Infection rates can be as high as 75% in puppies. Current treatments are failing due to poor efficacy, resistance and poor adherence to treatment schedules. We have identified a novel, extremely rapid acting series of compounds capable of single shot eradication of Giardia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical staples and chemical probes to dissect dynamins cellular roles.
-
批准号:DP240100514
-
项目类别:Discovery Projects
-
资助金额:$70.28万
-
财政年份:2024
-
负责人:Prof Adam McCluskey
-
依托单位:
Micro-dissection of clathrins role in mitosis via chemical biology probes
-
批准号:DP180101781
-
项目类别:Discovery Projects
-
资助金额:$56.66万
-
财政年份:2018
-
负责人:Prof Adam McCluskey
-
依托单位:
Pushing The Boundaries Of Flow Chemistry – Towards New Anti-Viral Agents
-
批准号:DP140101565
-
项目类别:Discovery Projects
-
资助金额:$29.17万
-
财政年份:2014
-
负责人:Prof Adam McCluskey
-
依托单位:
Dual purpose contraception
-
批准号:nhmrc : GNT1066326
-
项目类别:Project Grants
-
资助金额:$43.94万
-
财政年份:2014
-
负责人:Prof Adam McCluskey
-
依托单位:
An integrated liquid chromatography mass spectrometry nuclear magnetic resonance (LC-MS-NMR) facility for applications in proteomics and organic chemistry
-
批准号:LE100100142
-
项目类别:Linkage Infrastructure, Equipment and Facilities
-
资助金额:$33.34万
-
财政年份:2010
-
负责人:Prof Adam McCluskey
-
依托单位:
Streamlining the dynamin epilepsy drug pipeline
-
批准号:DP1095780
-
项目类别:Discovery Projects
-
资助金额:$30.51万
-
财政年份:2010
-
负责人:Prof Adam McCluskey
-
依托单位:
Chemical listening devices: Novel sensors targeting the clandestine manufacture and transport of illicit drugs and explosives.
-
批准号:LP0775378
-
项目类别:Linkage Projects
-
资助金额:$26.28万
-
财政年份:2008
-
负责人:Prof Adam McCluskey
-
依托单位:
The discovery and validation of novel drug classes against parasites with the potential for major economic impacts
-
批准号:LP0882285
-
项目类别:Linkage Projects
-
资助金额:$46.44万
-
财政年份:2008
-
负责人:Prof Adam McCluskey
-
依托单位:
Selective Detection and Removal of Contaminants That Have an Adverse Impact on Australian Raw Sugar Quality.
-
批准号:LP0453490
-
项目类别:Linkage Projects
-
资助金额:$13.22万
-
财政年份:2004
-
负责人:Prof Adam McCluskey
-
依托单位:
In-field sensors for the detection of illicit drugs
-
批准号:LP0454992
-
项目类别:Linkage Projects
-
资助金额:$13.75万
-
财政年份:2004
-
负责人:Prof Adam McCluskey
-
依托单位:
High Pressure and Fluorous Approaches to Fostriecin Libraries: New Therapeutic Opportunities.
-
批准号:DP0342988
-
项目类别:Discovery Projects
-
资助金额:$3.41万
-
财政年份:2003
-
负责人:Prof Adam McCluskey
-
依托单位:
国内基金
海外基金
登录
查看更多内容
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
-
批准号:82371224
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马柯
-
依托单位:
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨胜彩
-
依托单位:
泛素结合酶UBE2S调控GPX4/SLC7A11影响肝癌细胞铁死亡的机制研究
-
批准号:32060159
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:莫之婧
-
依托单位:
m6A识别蛋白YTHDF2促白血病细胞生长的研究
-
批准号:32070793
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:赵昀
-
依托单位:
TCF7L2突变介导SMAD7信号轴抑制KRAS突变型结直肠癌转移及耐药的分子机制研究
-
批准号:32000555
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:徐亮
-
依托单位:
PRMT1-meFOXO1通路在低温常压等离子体诱导的三阴型乳腺癌细胞铁死亡中的作用机制研究
-
批准号:31900528
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2019
-
负责人:王真
-
依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
-
批准号:61372188
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:陈秀杰
-
依托单位:
IL-6自主分泌介导的B细胞来源淋巴造血系统肿瘤耐药的相关机制研究
-
批准号:81172109
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:柳凤亭
-
依托单位: